NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Overview


NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

  • TABLET, EXTENDED RELEASE; ORAL: EQ 200MG BASE;120MG

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

FDA applicationDosage FormStrengthMarketing StatusCompany
NDA #076518TABLET, EXTENDED RELEASE; ORALEQ 200MG BASE;120MGOTCPERRIGO
Click on a application number to view drug details